These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33353723)

  • 61. Comparison of Alzheimer's disease with vascular dementia and non-dementia using specific voxel-based Z score maps.
    Ishii S; Shishido F; Miyajima M; Sakuma K; Shigihara T; Tameta T; Miyazaki M; Kuroda H
    Ann Nucl Med; 2009 Jan; 23(1):25-31. PubMed ID: 19205835
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A survey on applications and analysis methods of functional magnetic resonance imaging for Alzheimer's disease.
    Forouzannezhad P; Abbaspour A; Fang C; Cabrerizo M; Loewenstein D; Duara R; Adjouadi M
    J Neurosci Methods; 2019 Apr; 317():121-140. PubMed ID: 30593787
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mixed-Location Cerebral Microbleeds: An Imaging Biomarker for Cerebrovascular Pathology in Cognitive Impairment and Dementia in a Memory Clinic Population.
    Gyanwali B; Shaik MA; Venketasubramanian N; Chen C; Hilal S
    J Alzheimers Dis; 2019; 71(4):1309-1320. PubMed ID: 31524167
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive Decline.
    Corriveau RA; Bosetti F; Emr M; Gladman JT; Koenig JI; Moy CS; Pahigiannis K; Waddy SP; Koroshetz W
    Cell Mol Neurobiol; 2016 Mar; 36(2):281-8. PubMed ID: 27095366
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vascular dementia: clinical, neuroradiologic and neuropathologic aspects.
    Murray ME; Knopman DS; Dickson DW
    Panminerva Med; 2007 Dec; 49(4):197-207. PubMed ID: 18091672
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC).
    Rockwood K; Macknight C; Wentzel C; Black S; Bouchard R; Gauthier S; Feldman H; Hogan D; Kertesz A; Montgomery P
    Ann N Y Acad Sci; 2000 Apr; 903():522-8. PubMed ID: 10818547
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Role of Cerebrovascular Disease in Amyloid Deposition.
    Noh Y; Seo SW; Jeon S; Lee JM; Kim JS; Lee JH; Kim JH; Kim GH; Ye BS; Cho H; Kim HJ; Yoon CW; Choe YS; Lee KH; Weiner MW; Na DL
    J Alzheimers Dis; 2016 Oct; 54(3):1015-1026. PubMed ID: 27567803
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
    J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
    Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
    Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia.
    Bastos-Leite AJ; van der Flier WM; van Straaten EC; Staekenborg SS; Scheltens P; Barkhof F
    Stroke; 2007 Dec; 38(12):3182-5. PubMed ID: 17962598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intracranial stenosis in cognitive impairment and dementia.
    Hilal S; Xu X; Ikram MK; Vrooman H; Venketasubramanian N; Chen C
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):2262-2269. PubMed ID: 27488908
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Differential diagnosis of Alzheimer-type dementia and vascular dementia based on neuroimaging study].
    Hanyu H; Nakano S; Abe S; Arai H; Iwamoto T; Takasaki M
    No To Shinkei; 1995 Jul; 47(7):665-70. PubMed ID: 7612383
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
    Moon Y; Han SH; Moon WJ
    J Alzheimers Dis; 2016; 51(3):737-45. PubMed ID: 26890777
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cobalt-55 positron emission tomography in vascular dementia: significance of white matter changes.
    De Reuck J; Santens P; Strijckmans K; Lemahieu I;
    J Neurol Sci; 2001 Dec; 193(1):1-6. PubMed ID: 11718742
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Defining the neuropathological background of vascular and mixed dementia and comparison with magnetic resonance imaging findings.
    Gold G
    Front Neurol Neurosci; 2009; 24():86-94. PubMed ID: 19182466
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Single photon emission computed tomography, magnetic resonance imaging hyperintensity, and cognitive impairments in patients with vascular dementia.
    Cohen RA; Paul RH; Zawacki TM; Sethi M; Ott BR; Moser DJ; Stone W; Noto R; Gordon N
    J Neuroimaging; 2001 Jul; 11(3):253-60. PubMed ID: 11462291
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuropathological evaluation of mixed dementia.
    Jellinger KA; Attems J
    J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
    Kerrouche N; Herholz K; Mielke R; Holthoff V; Baron JC
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1213-21. PubMed ID: 16525414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.